maintain weightloss from glp-1 baton rouge Medical Weight Loss Plan Louisiana Medical Group | Weight

Limitations Direct clinical evidence for this specific molecule is limited

It just depends on the season of life and wellness goals at the time

Learning Objectives: List the two types of glucagon-like peptide-1 (GLP-1) medications approved for weight loss Describe the proposed mechanism of action for GLP-1s and glucose-dependent insulinotropic peptide (GIP) medications Explain where GLP receptors are found List three data points on efficacy outcomes of GLP-1s List five main side effects of GLP-1s Explain the relationship between GLP dose and side effects Describe what mindful eating is and how it can be used to help optimize nutritional status and ameliorate the side effects of GLP-1s List three pieces of motivational interviewing (MI) dialogue to help assess the impact of a GLP-1 to inform the counseling focus Using Mindful Eating with GLP-1 Medications webinar presents the benefits of coupling a mindful eating approach with weight loss medication for personalized and effective care

GIP Receptor Distribution: **Adipose tissue: Adipocyte metabolism, nutrient partitioning Brain: Modulates energy balance Bone: May positively influence bone metabolism Clinically, this translates into greater weight loss than GLP-1 aloneoften approaching or exceeding 20% of body weight in trials

Typical interventions consist of a protein-heavy diet to provide for muscle and collagen, regular sleep timing to take advantage of the better sleep so many experience, and moderate resistance training to grow lean mass

Pro-inflammatory cytokines alter the immunopeptidome landscape by modulation of HLA-B expression